The opportunities offered by the Smart Factory 4.0 transition for the Pharma sector are therefore enormous and companies certainly cannot afford to miss them, otherwise they will lose a key competitive lever.
The US is a highly developed mixed market economy. Moreover, it is one of the most technologically advanced and innovative economies, but the economy is expected to experience a slowdown in 2023.
An insight of the most recurrent challenges on a FOOD company operating in the US market and the most pressing issues deriving from the current social economical trends.
Bologna|Milano|Modena|Padova|New York|Orlando|New Delhi|Bangalore|Pune|Ho Chi Minh City|Hanoi|Seul